We thus investigated endogenous levels of PIM1, −2, and −3 in three mutant BRAF melanoma cell lines as well as cell lines rendered resistant to BRAF inhibitors (BR) (generated and characterized in [5]); fibroblasts were used as controls. The gene discussed is BRAF; the disease is melanoma.